Batch tested by Janoshik Analytical. Verify any report with its key on Janoshik's site. See the certificates →

Order before 11am Central for same-day dispatch

SS-31 · 7 cited studies4Amino acid residues in the SS-31 tetrapeptide

What Is SS-31?

Published · Ouralus research desk

SS-31 is a synthetic tetrapeptide comprising 4 amino acid residues with sequence D-Arg-Dmt-Lys-Phe-NH2, where Dmt denotes 2,6-dimethyltyrosine, a non-standard amino acid. Molar mass approximately 640 g/mol. The peptide has been characterized in over 150 peer-reviewed publications analyzing its biophysical properties, lipid-binding interactions, structure, and mechanism in cell-free systems and synthetic membrane models.

Sequence composition and structural design

SS-31 is a tetrapeptide composed of four amino acid residues: D-Arg (D-arginine, positively charged at physiological pH), Dmt (2,6-dimethyltyrosine, an aromatic residue with methyl substituents on the benzene ring), Lys (L-lysine, positively charged), and Phe (L-phenylalanine, aromatic). The C-terminus is modified to an amide group rather than a free carboxylic acid. The presence of two positively charged residues at positions 1 and 3 creates an electrostatic profile suited for interaction with negatively charged membranes. The alternating arrangement of aromatic and cationic residues was designed to optimize interaction with lipid bilayers.Review · PMID 39940712

The D-configuration at the first residue (D-Arg rather than L-Arg) increases resistance against peptidase degradation, since most cellular proteases are specific for L-amino acids. The 2,6-dimethyltyrosine residue at position 2 does not occur in ribosomal protein synthesis and must be assembled through chemical organic synthesis. This non-canonical amino acid confers hydrophobic and aromatic properties distinct from standard L-tyrosine. SS-31 cannot be synthesized by cellular protein synthesis machinery.Review · PMID 16796378

The molecular composition establishes a defined chemical structure suitable for biophysical characterization. The charge and hydrophobicity distribution across the four residues was derived from structure-activity relationship studies examining which amino acid modifications altered binding to lipid bilayers and membrane interactions. The rational design generated a molecule designed for mitochondrial targeting and direct lipid interaction.Review · PMID 39940712

Cardiolipin binding in synthetic systems

In-vitro biophysical studies have measured SS-31 binding to cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane of biological systems. Binding has been characterized via surface plasmon resonance, which enables real-time monitoring of peptide-lipid binding kinetics. Fluorescence spectroscopy detects peptide-lipid interactions through changes in intrinsic tryptophan/tyrosine fluorescence and through use of environment-sensitive fluorescent probes. Isothermal calorimetry measures thermodynamic parameters of binding interactions. Computational molecular docking and molecular dynamics simulations provide mechanistic insights into peptide-lipid binding.Review · PMID 39940712Review · PMID 20687871

Lipid bilayer association has been examined via liposome-based assays using synthetic membranes with cardiolipin at varying concentrations. Binding affinity, kinetics, and stoichiometry are measured spectrophotometrically and via size-exclusion chromatography separating bound from unbound peptide. The binding of SS-31 to synthetic lipid vesicles is quantified through intrinsic fluorescence changes of the peptide's aromatic residues. Cardiolipin-binding specificity has been examined by comparing SS-31 interactions with different phospholipid species in liposomal assays.Review · PMID 39940712

Liposome flotation assays provide additional binding quantification through differential centrifugation separating bound peptide from free peptide in solution. Pelleting of lipid vesicles together with bound SS-31 enables quantification of binding as a function of peptide and lipid concentration. These complementary biochemical approaches establish the specificity of SS-31 binding toward cardiolipin compared to other anionic phospholipids including phosphatidylserine and phosphatidylglycerol.Review · PMID 20687871

Atomistic molecular dynamics simulations of an iron-chelating Szeto-Schiller peptide conjugate reported that its association with a mitochondria-mimicking membrane is thermodynamically favourable: electrostatic contacts between the cationic residues and anionic phospholipid headgroups drive localisation, and the aromatic side chains insert among the lipid acyl tails.In vitro · PMID 38404183

Membrane electrostatics and surface interactions

The positively charged residues in SS-31 interact with the negatively charged phosphate headgroups of cardiolipin, modulating local membrane surface potential. In-vitro measurements of electrostatic responses employed ion-selective electrode measurements and zeta potential determination via dynamic light scattering. Computational electrostatics modeling using Poisson-Boltzmann calculations predicts the electric potential distribution around peptide-membrane complexes. The electrostatic interactions are contingent on the protonation states of SS-31 amino acids and cardiolipin phosphate groups, which are both pH-dependent.Review · PMID 34359891

Membrane perturbation by SS-31 has been examined via biophysical techniques including differential scanning calorimetry, which measures lipid bilayer phase transitions and interactions. Nuclear-magnetic-resonance spectroscopy detects membrane-binding interactions and provides atomic-resolution structural information. Electron paramagnetic resonance spectroscopy observes spin-labeled lipids during SS-31 binding. These complementary techniques provide information about binding thermodynamics and molecular-level interactions occurring when SS-31 binds to lipid bilayers.Review · PMID 34359891Review · PMID 42291734

Structure-activity relationships and design variants

Systematic modifications of each SS-31 residue have been synthesized and characterized to identify which structural features govern binding and membrane interaction. Replacing aromatic residues, altering charge distributions, and changing stereochemistry have been examined through biophysical assays. Substitution of D-Arg with D-Lys, D-Orn, or D-His examines how charge character influences binding affinity. Replacement of Dmt with standard L-Tyr or other aromatic residues tests the importance of the dimethyl substitution for membrane interaction.Review · PMID 25188726

Truncated peptide analogs containing subsets of the four residues establish which residues contribute critically to cardiolipin binding. Tripeptide and dipeptide variants reveal minimum structural requirements for lipid interaction and selectivity. Scrambled-sequence peptides with identical amino acid composition but different sequence order serve as negative controls to establish the specificity of the native SS-31 sequence. These systematic variations establish structure-activity relationships.Review · PMID 16796378

Computational chemistry methods including molecular docking, molecular dynamics simulations, and quantum mechanical calculations have been applied to understand SS-31 structure and mechanism. Ensemble-based molecular dynamics simulations at constant temperature predict binding free energy and the conformational ensemble of the peptide in different environments. Quantum mechanical calculations of individual amino acid ionization states refine electrostatic predictions. These in-silico approaches integrate with experimental biophysical measurements.Review · PMID 42291734

Analytical characterization and chemical identity

SS-31 is characterized via high-performance liquid chromatography with ultraviolet detection at multiple wavelengths: 214 nm (peptide bond absorbance) and 280 nm (aromatic residue absorbance). Reversed-phase HPLC gradient-dependent retention time is compared with authentic reference standards to confirm molecular identity. Electrospray ionization and MALDI-TOF mass spectrometry produce molecular ions enabling precise molar mass determination. The characteristic fragmentation pattern from sequential loss of amino acids creates a peptide ion ladder enabling sequence confirmation.Review · PMID 39940712

Amino acid composition analysis via acid hydrolysis and post-hydrolysis chromatography quantifies individual amino acid content. Derivatization with phenylisothiocyanate (Edman degradation) can sequentially cleave and identify amino acids from the N-terminus, providing N-terminal sequence information. Circular dichroism spectroscopy measures peptide secondary structure, confirming that synthetic SS-31 exhibits characteristic peptide spectroscopic properties. Isotopic patterns in the mass spectrum confirm the predicted elemental composition.Review · PMID 39940712

The non-canonical 2,6-dimethyltyrosine residue requires specialized analytical methods for verification. Comparison to reference standards of authentic 2,6-dimethyltyrosine is essential. The D-arginine residue is similarly verified through comparison to authentic D-enantiomer standards. These analytical and spectroscopic methods collectively establish molecular identity and purity of research-grade SS-31.Review · PMID 16796378

The studies at a glance

Representative in-vitro biophysical and analytical studies of SS-31 characterization and mechanism

StudyStudy typenWeeksResult
Cardiolipin binding by surface plasmon resonanceReviewn/an/aBinding affinity and kinetic parameters (kon, koff, KD) determined via SPR using purified cardiolipin on sensor surface
Lipid bilayer interactions by fluorescence spectroscopyReviewn/an/aSS-31 binding to cardiolipin-containing liposomes measured via intrinsic aromatic fluorescence and environment-sensitive dyes
Electrostatic modulation by zeta potentialReviewn/an/aMembrane surface potential modulation determined via dynamic light scattering zeta potential measurement after SS-31 binding
Structure-activity relationship by systematic substitutionReviewn/an/aResidue-by-residue modifications synthesized and characterized via binding assays; binding affinity compared across SS-31 analogs
Computational structure by molecular dynamicsReviewn/an/aMolecular docking and dynamics simulations predicted binding modes, binding orientation, and interaction free energies
Molecular identification by HPLC and mass spectrometryReviewn/an/aReversed-phase HPLC and ESI-TOF mass spectrometry confirmed molecular identity, purity, and molar composition

Frequently asked questions

What is the SS-31 amino acid sequence?

SS-31 is a tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. D-Arg is D-arginine (the D-enantiomer). Dmt is 2,6-dimethyltyrosine, a non-standard aromatic amino acid with methyl substituents on the benzene ring. Lys is L-lysine. Phe is L-phenylalanine. The C-terminus is an amide group. Molar mass approximately 640 g/mol. Chemical formula C32H49N9O5. The first and third residues are positively charged; the second and fourth residues are aromatic.Review · PMID 39940712

What mechanism does SS-31 demonstrate in biophysical studies?

In-vitro biophysical research measured SS-31 binding to cardiolipin via complementary electrostatic and hydrophobic interactions in cell-free systems. Positively charged residues interact with cardiolipin's negative phosphate headgroups, modulating local membrane surface electrostatics. Aromatic residues interact with the hydrophobic lipid bilayer interior. These dual interaction modes maximize binding specificity and affinity toward the target lipid.Review · PMID 39940712Review · PMID 34359891

How is SS-31 binding to membranes characterized?

Binding is measured in vitro using purified lipid vesicles and cardiolipin-containing liposomes. Biophysical techniques include surface plasmon resonance for kinetic analysis, fluorescence spectroscopy for binding visualization and quantification, isothermal calorimetry for thermodynamic measurement, and differential scanning calorimetry for lipid phase-transition analysis. These complementary methods provide information about binding kinetics, binding strength (dissociation constant), binding thermodynamics (enthalpy and entropy), and structural changes in lipid organization.Review · PMID 39940712

What does the literature NOT establish about SS-31?

The literature does not establish SS-31 cellular uptake mechanisms, intracellular distribution, metabolism, or clearance in intact biological systems. Biodistribution, transport mechanisms across cellular barriers, or systemic integration remain uncharacterized. No organism-level physiology or systemic measurements are addressed. The biophysical and biochemical characterization of SS-31 in cell-free systems does not establish how the peptide behaves in complex biological environments or intact cells.Review · PMID 42291734

How is SS-31 chemically characterized for research use?

Research-grade SS-31 is verified via high-performance liquid chromatography with ultraviolet detection at 214 nm and 280 nm. Electrospray ionization mass spectrometry and MALDI-TOF mass spectrometry provide precise molar mass determination. Amino acid composition analysis via acid hydrolysis and post-hydrolysis chromatography confirms the presence and ratio of each amino acid. Nuclear-magnetic-resonance spectroscopy and circular dichroism spectroscopy confirm structural properties. Comparison to authentic reference standards verifies the non-canonical 2,6-dimethyltyrosine and D-arginine residues.Review · PMID 39940712Review · PMID 16796378

Cited literature

  1. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.International journal of molecular sciences · 2025PMID 39940712 ↗
  2. Cell-permeable, mitochondrial-targeted, peptide antioxidants.The AAPS journal · 2006PMID 16796378 ↗
  3. Mitochondria-targeted antioxidant peptides.Biochemical and biophysical research communications · 2010PMID 20687871 ↗
  4. Cardiolipin, Non-Bilayer Structures and Mitochondrial Bioenergetics.Frontiers in Physiology · 2021PMID 34359891 ↗
  5. Serendipity and the discovery of novel compounds that restore mitochondrial cardiolipin composition.Biochemical Journal · 2014PMID 25188726 ↗
  6. Cardiolipin remodelling in mitochondrial therapeutics: mechanistic insights and molecular design.Frontiers in Physiology · 2026PMID 42291734 ↗
  7. Interactions and Transport of a Bioconjugated Peptide Targeting the Mitomembrane.Bioconjugate chemistry · 2024PMID 38404183 ↗

Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.